BOTWOOD NICHOLAS A.J.

PrivateCIK: 2066784
Location

NEW YORK, NY

BOTWOOD NICHOLAS A.J. (Head of R&D, CMO) sold 51.8% of their position (65.52K shares) of SYNDAX PHARMACEUTICALS INC on the open market

Open‑market sale worth $1.18M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderBOTWOOD NICHOLAS A.J.CIK 2066784
Officer· Head of R&D, CMO
Since Feb 2026
+41.98K
Net shares
Net buyer
$1.18M
Total sold
2
Open market trades
0B · 2S
6
Total transactions
107.50K acquired · 65.52K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+22.52K

Price / share

$13.82

Trade value

$311.16K

% of position

31.0%
6/11/2026
72.65K95.17K

Common Stock

Direct
S · Sale

Shares

34.28K

Price / share

$18.00

Trade value

$617.04K

% of position

36.0%
6/11/2026
95.17K60.88K

Common Stock

Direct
M · Option Exercise

Shares

+31.23K

Price / share

$13.82

Trade value

$431.67K

% of position

51.3%
6/12/2026
60.88K92.12K

Common Stock

Direct
S · Sale

Shares

31.23K

Price / share

$18.14

Trade value

$566.60K

% of position

33.9%
6/12/2026
92.12K60.88K
Total

Net shares

11.77K

Net value

-$440.82K

Derivative Transactions2

Stock options (Right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

22.52K shares

Shares

+22.52K

Strike price

13.82

Held after

0.00

Exercisable

6/11/2026

Stock options (Right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

31.23K shares

Shares

+31.23K

Strike price

13.82

Held after

0.00

Exercisable

6/12/2026
BOTWOOD NICHOLAS A.J. — Insider Transaction (Form 4) Filed Jun 12, 2026 | Finecho